4
Changes in Ownership
Stoke Therapeutics, Inc. Filed Acc 0001966716-25-000009
GENERAL COUNSEL & CORP SEC sold 3,978 shares at an average $32.28 ($128,411)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Allan Jonathan GENERAL COUNSEL & CORP SEC | 2025-12-08 | Sale 10b5-1 | −1,300 | $31.60 | $41,074 | 14,509 | D: show line 1 in the form |
| Allan Jonathan GENERAL COUNSEL & CORP SEC | 2025-12-08 | Sale 10b5-1 | −2,678 | $32.61 | $87,337 | 11,831 | D: show line 2 in the form |
| Open-market sales · 3,978 sh · avg $32.28 · $128,411 | |||||||
Loading xslF345X05/form4-12102025_091230.xml…